A federal judge has approved a criminal sentence for Purdue Pharma, the manufacturer of OxyContin, as part of a legal settlement that addresses thousands of lawsuits linked to the opioid crisis. This ruling marks a significant step towards the dissolution of Purdue Pharma, which is expected to be completed by the end of the week. The new entity that will emerge from this process is designed to prioritize public health initiatives, following a comprehensive investigation by the U.S. Department of Justice.
Related Articles
Don't miss out on breaking stories and in-depth articles.